title: No change to HIV-1 latency with valproate therapy.
authors.forename: Alan
authors.initials: A
authors.lastname: Steel
authors.forename: Sally
authors.initials: S
authors.lastname: Clark
authors.forename: Ian
authors.initials: I
authors.lastname: Teo
authors.forename: Sunil
authors.initials: S
authors.lastname: Shaunak
authors.forename: Mark
authors.initials: M
authors.lastname: Nelson
authors.forename: Brian
authors.initials: B
authors.lastname: Gazzard
authors.forename: Peter
authors.initials: P
authors.lastname: Kelleher
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014635:Valproic Acid / Q000627:therapeutic use*; D017735:Virus Latency / Q000187:drug effects
chemical_list: D044966:Anti-Retroviral Agents; D000927:Anticonvulsants; D014635:Valproic Acid